niacinamide has been researched along with Postoperative Complications in 23 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Liver resection can be considered in some hepatocellular carcinoma (HCC) patients who received sorafenib." | 7.79 | Safety of liver resection for hepatocellular carcinoma after sorafenib therapy: a multicenter case-matched study. ( Barbier, L; Belghiti, J; Faivre, S; Fuks, D; Le Treut, YP; Muscari, F; Pessaux, P, 2013) |
| "Iodine-induced hyperthyroidism has been frequently described when iodine is introduced into an iodine-deficient area." | 7.67 | Five patients with iodine-induced hyperthyroidism. ( Braverman, LE; Mordes, JP; Rajatanavin, R; Safran, M; Stoller, WA, 1984) |
| "Recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) is a rare but challenging condition." | 5.39 | Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation. ( Ganten, TM; Hoffmann, K; Koschny, R; Mehrabi, A; Pfeiffenberger, J; Radeleff, B; Schemmer, P; Schmitz, A; Stremmel, W, 2013) |
| "Liver resection can be considered in some hepatocellular carcinoma (HCC) patients who received sorafenib." | 3.79 | Safety of liver resection for hepatocellular carcinoma after sorafenib therapy: a multicenter case-matched study. ( Barbier, L; Belghiti, J; Faivre, S; Fuks, D; Le Treut, YP; Muscari, F; Pessaux, P, 2013) |
| "Iodine-induced hyperthyroidism has been frequently described when iodine is introduced into an iodine-deficient area." | 3.67 | Five patients with iodine-induced hyperthyroidism. ( Braverman, LE; Mordes, JP; Rajatanavin, R; Safran, M; Stoller, WA, 1984) |
| "Their hematological malignancies were well-controlled at the time of liver resection." | 1.46 | Liver resection for hepatocellular carcinoma in patients with hematological malignancies. ( Cheng, SB; Huang, CC; Jan, YG; Lin, HC; Lin, YL; P'eng, FK; Shen, CH; Teng, CJ; Wu, CC; Yang, YS, 2017) |
| "Recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) is a rare but challenging condition." | 1.39 | Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation. ( Ganten, TM; Hoffmann, K; Koschny, R; Mehrabi, A; Pfeiffenberger, J; Radeleff, B; Schemmer, P; Schmitz, A; Stremmel, W, 2013) |
| " In order to maximize the benefit of sorafenib and other investigational agents for patients with advanced disease, effective interventions have been designed to mitigate their associated adverse events, such as hand-foot skin reactions and hypertension." | 1.36 | Clinical roundtable monograph. Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma. ( Abou-Alfa, GK; Gish, RG; Tong, MJ, 2010) |
| "The development of targeted agents for renal cell carcinoma has renewed interest in consolidative surgery due to the robust clinical responses seen with these agents." | 1.35 | Surgical resection of renal cell carcinoma after targeted therapy. ( Campbell, SC; Fergany, A; Garcia, JA; Gill, IS; Klein, EA; Krishnamurthi, V; Novick, AC; Rini, BI; Stephenson, AJ; Thomas, AA; Zhou, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 16 (69.57) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, JA | 1 |
| Frank, BS | 1 |
| Urban, TT | 1 |
| Twite, M | 1 |
| Jaggers, J | 1 |
| Khailova, L | 1 |
| Klawitter, J | 1 |
| Li, G | 1 |
| Mu, X | 1 |
| Huang, X | 1 |
| Qian, X | 1 |
| Qin, J | 1 |
| Tan, Z | 1 |
| Zhang, W | 1 |
| Xu, X | 1 |
| Tan, S | 1 |
| Zhu, Z | 1 |
| Li, W | 1 |
| Wang, X | 2 |
| Sun, B | 1 |
| Lin, HC | 1 |
| Yang, YS | 1 |
| Teng, CJ | 1 |
| Shen, CH | 1 |
| Jan, YG | 1 |
| Cheng, SB | 1 |
| Wu, CC | 1 |
| Lin, YL | 1 |
| Huang, CC | 1 |
| P'eng, FK | 1 |
| Dubivska, S | 1 |
| Kudinova, O | 1 |
| Grigorov, Y | 1 |
| Bitchuk, N | 1 |
| Skrypko, V | 1 |
| Pasko, A | 1 |
| Churpiy, I | 1 |
| Kovalenko, A | 1 |
| Zaplutanov, V | 1 |
| Lebedeva, EA | 1 |
| Scoblo, ML | 1 |
| Adleba, LZ | 1 |
| Lokhmanova, VV | 1 |
| Barbier, L | 1 |
| Fuks, D | 1 |
| Pessaux, P | 1 |
| Muscari, F | 1 |
| Le Treut, YP | 1 |
| Faivre, S | 1 |
| Belghiti, J | 1 |
| Pfeiffenberger, J | 1 |
| Koschny, R | 1 |
| Hoffmann, K | 1 |
| Mehrabi, A | 1 |
| Schmitz, A | 1 |
| Radeleff, B | 1 |
| Stremmel, W | 1 |
| Schemmer, P | 1 |
| Ganten, TM | 1 |
| Tsygan, IV | 1 |
| Nagai, S | 1 |
| Mangus, RS | 1 |
| Kubal, CA | 1 |
| Ekser, B | 1 |
| Fridell, JA | 1 |
| Klingler, KR | 1 |
| Maluccio, MA | 1 |
| Tector, AJ | 1 |
| Golub, IY | 1 |
| Beloborodov, VA | 1 |
| Sorokina, LV | 2 |
| Kur'yanov, AA | 1 |
| Borisova, VM | 1 |
| Thomas, AA | 1 |
| Rini, BI | 1 |
| Stephenson, AJ | 1 |
| Garcia, JA | 1 |
| Fergany, A | 1 |
| Krishnamurthi, V | 1 |
| Novick, AC | 1 |
| Gill, IS | 1 |
| Klein, EA | 1 |
| Zhou, M | 1 |
| Campbell, SC | 1 |
| Bose, D | 1 |
| Meric-Bernstam, F | 1 |
| Hofstetter, W | 1 |
| Reardon, DA | 1 |
| Flaherty, KT | 1 |
| Ellis, LM | 1 |
| Harshman, LC | 1 |
| Yu, RJ | 1 |
| Allen, GI | 1 |
| Srinivas, S | 1 |
| Gill, HS | 1 |
| Chung, BI | 1 |
| Gish, RG | 1 |
| Abou-Alfa, GK | 1 |
| Tong, MJ | 1 |
| Kardash, OF | 1 |
| Shestakova, LG | 1 |
| Krachak, DI | 1 |
| Chernookiĭ, OG | 1 |
| Zasetskiĭ, AE | 1 |
| Ostrovskiĭ, IuP | 1 |
| Bagnenko, SF | 1 |
| Mirzabaev, AT | 1 |
| Batotsyrenov, BV | 1 |
| Gorbachev, NB | 1 |
| Miroshnichenko, VN | 1 |
| Batotsyrenova, KhV | 1 |
| Velikiĭ, KF | 1 |
| Golub, IE | 1 |
| Pinskiĭ, SB | 1 |
| Ivankova, EN | 1 |
| Kovalenko, AL | 1 |
| Isbir, CS | 1 |
| Ak, K | 1 |
| Kurtkaya, O | 1 |
| Zeybek, U | 1 |
| Akgün, S | 1 |
| Scheitauer, BW | 1 |
| Sav, A | 1 |
| Cobanoglu, A | 1 |
| MANUKIAN, RS | 1 |
| Eng, FC | 1 |
| Easson, AM | 1 |
| Szentgyorgyi, E | 1 |
| Knox, JJ | 1 |
| Margulis, V | 1 |
| Matin, SF | 1 |
| Tannir, N | 1 |
| Tamboli, P | 1 |
| Swanson, DA | 1 |
| Jonasch, E | 1 |
| Wood, CG | 1 |
| Rajatanavin, R | 1 |
| Safran, M | 1 |
| Stoller, WA | 1 |
| Mordes, JP | 1 |
| Braverman, LE | 1 |
1 review available for niacinamide and Postoperative Complications
| Article | Year |
|---|---|
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic A | 2010 |
3 trials available for niacinamide and Postoperative Complications
| Article | Year |
|---|---|
[COGNITIVE ABNORMALITIES IN POSTOPERATIVE PERIOD OF THYROID SURGERY].
Topics: Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Drug Combinations; Female; Flavin | 2015 |
[Effect of cytoflavin on the recovery of cognitive function after the cardiaс surgery with artificial blood circulation].
Topics: Assisted Circulation; Cognition; Cognition Disorders; Drug Combinations; Female; Flavin Mononucleoti | 2011 |
[Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period].
Topics: Adult; Antioxidants; Drug Combinations; Endotoxemia; Female; Flavin Mononucleotide; Free Radicals; H | 2011 |
19 other studies available for niacinamide and Postoperative Complications
| Article | Year |
|---|---|
Serum metabolic profile of postoperative acute kidney injury following infant cardiac surgery with cardiopulmonary bypass.
Topics: Acute Kidney Injury; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Humans; Infant; Kynurenine | 2021 |
Liver transplantation using the otherwise-discarded partial liver resection graft with hepatic benign tumor: Analysis of a preliminary experience on 15 consecutive cases.
Topics: Adult; Aged; Antineoplastic Agents; Blood Vessel Prosthesis; End Stage Liver Disease; Female; Hepate | 2017 |
Liver resection for hepatocellular carcinoma in patients with hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biomarkers; Carcinoma, Hepatocellul | 2017 |
[TACTICS OF CHOOSING COGNITIVE DYSFUNCTION THERAPY IN THE POSTOPERATIVE PERIOD].
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Cognition Disorders; Cytidine Diphosphate Choline; Drug | 2017 |
SURGICAL PREVENTION AND TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM IN PATIENTS OPERATED ON THYROID GLAND.
Topics: Antioxidants; Drug Combinations; Flavin Mononucleotide; Humans; Hypoparathyroidism; Hypoxia; Inosine | 2018 |
[Variants of postoperative delirium suppression in elderly patients.]
Topics: Aged; Antioxidants; Delirium; Drug Combinations; Flavin Mononucleotide; Humans; Inosine Diphosphate; | 2019 |
Safety of liver resection for hepatocellular carcinoma after sorafenib therapy: a multicenter case-matched study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Transfusion; Carcinoma, Hepatocellular; | 2013 |
Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Humans; Immunosuppressive Agents; Liver Neoplasms; L | 2013 |
[Cerebral dysfunction after coronary artery bypass graft surgery with cardiopulmonary bypass].
Topics: Aged; Brain Diseases; Cardiopulmonary Bypass; Cognitive Dissonance; Drug Combinations; Female; Flavi | 2013 |
Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Hepatocellular; Combined Modality Therapy; Foll | 2015 |
Surgical resection of renal cell carcinoma after targeted therapy.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2009 |
Surgical outcomes and complications associated with presurgical tyrosine kinase inhibition for advanced renal cell carcinoma (RCC).
Topics: Aged; Carcinoma, Renal Cell; Cohort Studies; Combined Modality Therapy; Female; Humans; Indoles; Kid | 2013 |
Clinical roundtable monograph. Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.
Topics: Ablation Techniques; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Humans; Li | 2010 |
[Prevention of cognitive dysfunction in patients operated on thyroid gland].
Topics: Adolescent; Adult; Aged; Antioxidants; Cognition Disorders; Drug Combinations; Drug Monitoring; Fema | 2011 |
Ischemic preconditioning and nicotinamide in spinal cord protection in an experimental model of transient aortic occlusion.
Topics: Animals; Aortic Aneurysm; Apoptosis; Energy Metabolism; Infusions, Intra-Arterial; Ischemic Precondi | 2003 |
[Clinical features of certain surgical diseases and postoperative complications in vitamin PP deficiency].
Topics: Humans; Niacinamide; Pellagra; Postoperative Complications | 1958 |
Sorafenib and surgical complications: a case report of adverse reaction to sorafenib during treatment for renal cell carcinoma.
Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Colonic Diseases; Colonoscop | 2009 |
Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic A | 2008 |
Five patients with iodine-induced hyperthyroidism.
Topics: Adult; Amiodarone; Chlorobutanol; Coloring Agents; Coronary Artery Bypass; Drug Combinations; Female | 1984 |